Table 1.
Ref. | Number of patients | Definition of muscle wasting | Method of assessment | Prevalence of muscle wasting according to etiology |
Montano-Loza et al[14], 2014 | 112 | L3-SMI (≤ 52.4 cm2/m2 in men, ≤ 38.5 cm2/m2 in women) | CT scan | Alcohol: 44%, HCV: 46.9%, Alcohol + HCV: 38.9%, HBV: 0, AILD: 42.9%, Other: 21.4% |
Hanai et al[16], 2015 | 130 | L3-SMI (≤ 52.4 cm2/m2 in men, ≤ 38.5 cm2/m2 in women) | CT scan | HBV: 73.3%, HCV: 67.2%, Alcohol: 82.8%, Other: 50% |
Meza-Junco et al[18], 2013 | 116 | L3-SMI (≤ 41 cm2/m2 in women, and ≤ 53 cm2/m2 in men with body mass index ≥ 25 and ≤ 43 cm2/m2 in patients with BMI < 25) | CT scan | Alcohol: 53.8%, HCV: 20.8%, HCV+Alcohol: 40.3%, HBV: 25%, NASH: 62.5%, Other: 33.3% |
Hayashi et al[7], 2013 | 50 | SMI (< 6.87 kg/m2 in men, < 5.46 kg/m2 in women) and/or Muscle strength (< 24 kg in men, < 14 kg in women) | BIAHand Grip Strength | Viral: 40% |
Montano-Loza et al[24], 2014 | 248 | L3-SMI (≤ 41 cm2/m2 in women, and ≤ 53 cm2/m2 in men with body mass index ≥ 25 and ≤ 43 cm2/m2 in patients with BMI < 25) | CT scan | Alcohol: 52.2%, HCV: 40.9%, AILS: 40.5%, HBV: 47.6%, NASH: 71.4%, Other: 33.3% |
Krell et al[25], 2013 | 207 | L4-TPA (lowest sex-stratified tertile) | CT scan | HCV: 40.7%, HBV: 22.2%, HCC: 19.2%, Acohol: 36.7%, PSC: 28.6%, PBC: 40%, AIH: 36.4%, NASH: 25%, Other: 39.3% |
SMI: Skeletal muscle index; L3: Third lumbar vertebra; CT: Computed tomography; BIA: Bioelectrical impedance analysis; NASH: Non-alcoholic steatohepatitis; AILS: Autoimmune liver diseases; TPA: Total psoas area; HCC: Hepatocellular carcinoma; PSC: Primary sclerosing cholangitis; PBC: Primary biliary cirrhosis; AIH: Autoimmune hepatitis.